Cargando…
Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?
Autores principales: | do Rosário Souza, Mariana, Silva da Paz, Wandklebson, dos Santos Sales, Vinícius Barbosa, Hilario de Jesus, Gleidson Felipe, dos Santos Tavares, Débora, Almeida Lima, Shirley V. M., Lopes Sousa, Álvaro Francisco, Vieira de Melo, Enaldo, Feliciano do Carmo, Rodrigo, Freire de Souza, Carlos Dornels, Bezerra-Santos, Márcio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486810/ https://www.ncbi.nlm.nih.gov/pubmed/36147336 http://dx.doi.org/10.3389/fphar.2022.999301 |
Ejemplares similares
-
Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?
por: Souza, Mariana do Rosário, et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study
por: da Paz, Wandklebson Silva, et al.
Publicado: (2022) -
Basic and associated causes of schistosomiasis-related mortality in Brazil: A population-based study and a 20-year time series of a disease still neglected
por: Silva da Paz, Wandklebson, et al.
Publicado: (2021) -
Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?
por: do Carmo, Rodrigo Feliciano, et al.
Publicado: (2022) -
A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018
por: de Brito, Rodrigo José Videres Cordeiro, et al.
Publicado: (2022)